secwatch.observer — SEC 8-K summary
======================================

Issuer:     INSULET CORP (PODD)
CIK:        0001145197
Form:       8-K
Filed at:   2023-02-23T23:59:59+00:00
Accession:  0001145197-23-000019
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Insulet FY2022 revenue $1.3B (+19% YoY); Q4 revenue $369.7M (+20%); beats guidance; adjusted EPS $1.28
--------------------------------------------------------------------------------

- Full year 2022 revenue $1.3B, up 18.8% (22.2% constant currency), exceeding guidance of 18-19% constant currency.
- Omnipod revenue $1.2B (+23.4%); U.S. Omnipod $884.8M (+35.8%); International $363.0M (+0.9% reported, +12.1% constant currency).
- GAAP net income $4.6M ($0.07 diluted EPS); adjusted net income $91.1M ($1.28 diluted EPS) excluding $57.9M MDC charge, $25.2M legal costs, $3.4M CEO transition costs.
- Gross margin 61.7% (down 670 bps); adjusted gross margin 66.2% excluding $57.9M charge for voluntary medical device correction notices for Omnipod DASH PDMs and Omnipod 5 Controllers.
- Q4 2022 revenue $369.7M (+20.1% reported, +22.6% constant currency); U.S. Omnipod revenue $276.2M (+45.0%).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1145197/000114519723000019/0001145197-23-000019-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1145197/000114519723000019/podd-20230223.htm
  HTML page:      https://secwatch.observer/filing/0001145197-23-000019

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer